Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Zheng Ouyang
Purdue University, Department: Engineering (All Types)
Should you be removed from our database? Contact us at [email protected]. Read more below.
PurSpec Technologies, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
PurSpec Technologies, Inc. aims to develop and commercialize miniature mass spectrometry systems for chemical analysis. As part of this NIH sponsored project, the Investigators will develop a mass spectrometry analysis system and a protocol that can be applied for chemical analysis at the point of care for medical diagnosis. Specifically, the first aim of the project is to develop a miniature mass spectrometer that has compact size, low cost of ownership and maintenance with adequate performance for quantitative analysis. The second and third aims are to develop sample cartridges for direct analysis of blood samples and an operational protocol that allows this system to be used by nurses and physicians, who do not need to have special training in chemical analysis using mass spectrometry. These specific aims are, or may become relevant for the business scope and activities of PurSpec Technologies, Inc.
Development of a Point-of-Care Mass Spectrometry Analysis System
The proposed research has the potential to lead to the development of a first point-of- care mass spectrometry system for direct analysis of raw biological samples. It has strong relevance to general public health by providing a powerful tool for fast, easy, highly sensitive, selective and quantitative chemical monitoring for clinical diagnosis or personal health care.
Filed on August 17, 2015.
Tell us what you know about Zheng Ouyang's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Zheng Ouyang”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Zheng Ouyang | University of Colorado Denver | Conflict of Interest | Purdue University | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.